-transparent.png){kind=logo}
Young SHR were treated with propranolol (16 or 64 mg/kg per day) from 6 up to 14 weeks of age. Systolic blood pressure was significantly lower in SHR treated with propranolol (64 mg/kg) than in untreated SHR; no effect was seen in SHR treated with 16 mg/kg. The hemodynamic characteristics of the hindquarter vascular beds did not significantly differ between untreated and propranolol-treated SHR. Adult SHR were given propranolol (64 mg/kg per day) from 5 up to 8 months of age. Moderate reduction of systolic blood pressure was observed from 2 to 3 months of propranolol treatment. The cardiovascular pressor response to noradrenaline decreased in propranolol-treated SHR, while the decreased responsiveness was not found after pithing.
T Kubo, and
K Esumi, and
K Ennvu
December 1978,
Cardiovascular research,
T Kubo, and
K Esumi, and
K Ennvu
April 1975,
Acta physiologica Scandinavica,
T Kubo, and
K Esumi, and
K Ennvu
July 1992,
Journal of hypertension,
T Kubo, and
K Esumi, and
K Ennvu
January 1992,
The Tohoku journal of experimental medicine,
T Kubo, and
K Esumi, and
K Ennvu
June 1991,
Hypertension (Dallas, Tex. : 1979),
T Kubo, and
K Esumi, and
K Ennvu
January 1980,
Hypertension (Dallas, Tex. : 1979),
T Kubo, and
K Esumi, and
K Ennvu
April 1985,
Japanese journal of pharmacology,
T Kubo, and
K Esumi, and
K Ennvu
January 1989,
Journal of hypertension,
T Kubo, and
K Esumi, and
K Ennvu
March 1990,
Clinical and experimental pharmacology & physiology,
T Kubo, and
K Esumi, and
K Ennvu
October 1973,
Canadian journal of physiology and pharmacology,
